MolNFT v1 · #68915 · protein
Crystal structure of an oxidoreductase from methanosarcina mazei. northeast structural genomics consortium target id MAR208
3KA7: “Crystal structure of an oxidoreductase from methanosarcina mazei. northeast structural genomics consortium…”. X-ray diffraction, 1 ligand (FAD), 3 pockets (best druggability 0.86). MolNFT v1 #68915 on GenesisL1: 3D structure…
- PDB
- 3KA7
- Type
- protein
- Length
- 422 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Oxidoreductase
- UniProt
- Q8PU56
- Ligands
- FAD
- Pockets
- 3 · best druggability 0.86
Structure
x-ray diffraction · 1 distinct chain · 36% helix, 26% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Oxidoreductase | protein | 422 | 36% helix, 26% strand | Q8PU56 |
Ligands and binding sites
- FAD · Flavin-adenine dinucleotide · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 838 | 0.86 | 0.88 | 98 | FAD |
| 2 | 70 | 0.43 | 0.81 | 19 | empty |
| 3 | 59 | 0.38 | 0.79 | 13 | empty |
Modifications
Observed in the structure: 10 modified (engineered).
Compared structures
- 3KA7 · Crystal Structure of an oxidoreductase from Methanosarcina mazei. Northeast Structural… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8PU56
- Elsewhere: RCSB PDB 3KA7 · PDBe 3KA7 · UniProt Q8PU56
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.